ELAVL4 and Alzheimer disease: The results showed that NEFM was differentially expressed in different status of AD; namely, ENO2 and ELAVL4 were differentially expressed in different sexes of AD patients, while the expression of remaining genes showed no significant difference in these clinical features (Figure 5).